Sourcing & Evaluation Source and evaluate external capabilities, technologies, and assets across all three pillars, drawing on drug discovery expertise and LSMD strategic needs. Maintain a structured pipeline of external opportunities (asset acquisitions, research collaborations, discovery partnerships) with clear status tracking, strategic fit assessment, and next steps. Relationship Building & Ecosystem Engagement Build and sustain relationships across biotech, venture capital, academic, and CRO ecosystems to surface aligned opportunities. Represent SM E&I at partnering events (JPM, BIO, BioEurope), venture showcases, and scientific conferences. Due Diligence & Governance Lead cross-functional scientific due diligence by coordinating input from medicinal chemistry, computational chemistry, automation, pharmacology, biophysics, and AI/ML. Author structured evaluation reports, investment theses, and governance presentations for senior leadership. Competitive Intelligence & Strategy Maintain a living competitive landscape across SM E&I key technology domains (partnership activity, licensing transactions, acquisitions, and emerging science). Translate landscape intelligence into actionable strategic recommendations. Cross-Functional Collaboration Partner with Therapeutic Area Search & Evaluate, Lilly Research Labs, Catalyze360, and Corporate BD to ensure portfolio coherence and execution quality. Basic Qualifications PhD (7+ years) or Master’s (10+ years) in pharmaceutical or biotechnology R&D with foundation in drug discovery or translational science. 3+ years in external innovation/search and evaluation/business development scouting (or similar) involving systematic evaluation of external scientific opportunities. Additional Skills/Preferences Broad drug discovery literacy (chemistry, biology, pharmacology, AI/ML, automation, translational science) with ability to coordinate/synthesize specialist input. Experience leading structured scientific due diligence for licensing/collaboration/investment. Strong written communication for evaluation reports/governance materials. Familiarity with external biotech/health-tech ecosystem, including venture-backed/early-stage engagement. Familiarity with at least two technology areas: macrocyclic drug design, targeted protein degradation, AI/ML-driven drug discovery, automation, protein–protein interaction modulators, DNA-encoded libraries. Exposure to deal structures (research collaborations, licensing, option agreements, asset acquisitions). Strong business sense; ability to persuade/influence; track record building trust across functions. Ability to manage multiple concurrent evaluations; collaborative, high-autonomy team fit. Additional Information Supports work across Diabetes/Obesity/Cardiometabolic, Neuroscience, Immunology, Oncology, Genetic Medicines, Advanced Modalities. Up to 40% travel (domestic and international). Benefits (as explicitly stated) Company bonus for full-time equivalent employees (depending on company and individual performance). 401(k), pension, vacation; medical/dental/vision/prescription; flexible benefits; life insurance; time off/leave; well-being benefits (EAP, fitness, clubs/activities). #J-18808-Ljbffr